In Vitro and In Vivo Characterization of Potent Antileishmanial Methionine Aminopeptidase 1 Inhibitors

Leishmania major is the causative agent of cutaneous leishmaniasis (CL). No human vaccine is available for CL, and current drug regimens present several drawbacks, such as emerging resistance, severe toxicity, medium effectiveness, and/or high cost. Thus, the need for better treatment options agains...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Antimicrob Agents Chemother
Hoofdauteurs: Rodriguez, Felipe, John, Sarah F., Iniguez, Eva, Montalvo, Sebastian, Michael, Karina, White, Lyndsey, Liang, Dong, Olaleye, Omonike A., Maldonado, Rosa A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society for Microbiology 2020
Onderwerpen:
Experimental Therapeutics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7269496/
https://ncbi.nlm.nih.gov/pubmed/32179532
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01422-19
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items